Khai Loon Kua is > 10% Shareholder of Cyclacel Pharmaceuticals, Inc.. Currently has a direct ownership of 242,477 shares of CYCC, which is worth approximately $1.25 Million. The most recent transaction as insider was on Oct 16, 2025, when has been sold 88,204 shares (Common Stock) at a price of $4.22 per share, resulting in proceeds of $372,220. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 242K
n/a 3M change
n/a 12M change
Total Value Held $1.25 Million

Khai Loon Kua Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 16 2025
SELL
Open market or private sale
$372,220 $4.22 p/Share
88,204 Reduced 26.67%
242,477 Common Stock
Oct 15 2025
SELL
Open market or private sale
$42,331 $5.66 p/Share
7,479 Reduced 2.21%
330,681 Common Stock
Sep 16 2025
SELL
Open market or private sale
$128,250 $5.13 p/Share
25,000 Reduced 6.88%
338,160 Common Stock
Sep 12 2025
SELL
Open market or private sale
$138,401 $6.22 p/Share
22,251 Reduced 5.77%
363,160 Common Stock
Sep 05 2025
SELL
Open market or private sale
$133,568 $7.01 p/Share
19,054 Reduced 4.71%
385,411 Common Stock
Sep 04 2025
BUY
Other acquisition or disposition
-
186,465 Added 31.55%
404,465 Common Stock
KLK

Khai Loon Kua

> 10% Shareholder
Johor Bahru, N8

Track Institutional and Insider Activities on CYCC

Follow Cyclacel Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYCC shares.

Notify only if

Insider Trading

Get notified when an Cyclacel Pharmaceuticals, Inc. insider buys or sells CYCC shares.

Notify only if

News

Receive news related to Cyclacel Pharmaceuticals, Inc.

Track Activities on CYCC